您的位置：
Toceranib
(Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide
98% ( Chemicell/科米賽爾)
| CAS號(hào) | 356068-94-5 | 試劑別名 | Z)-5-(5-氟-2-氧代-2,3-二氫-1H-吲哚-3-亞基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;(Z)-5-(5-氟-2-氧代-2,3-二氫-1H-吲哚-3-亞基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;5'-O-乙?；?2'3'-O-異亞丙基腺苷 |
| 分子式 | C22H25FN4O2 | ||
| 分子量 | 396.46 | ||
| 英文名稱： | (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide |
| 英文別名： | (Z)-5-(5-Fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide;Toceranib;(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-N-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrrole-3-carboxamide;5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;SU-11654;Toceranib Discontin;ToceranibDiscontinued Pfizer Patent issues;5-(5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide;5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide;PHA 291639;PHA-291639;SU 11654;5-[(5Z)-(5-Fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrrole-3-carboxamide;SU11654;5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-N-[2-(1-pyrrolidinyl)ethyl]-1H-pyrrole-3-carboxamide |
| 中文別名： | Z)-5-(5-氟-2-氧代-2,3-二氫-1H-吲哚-3-亞基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;(Z)-5-(5-氟-2-氧代-2,3-二氫-1H-吲哚-3-亞基甲基)-2,4-二甲基-N-[2-(1-吡咯烷基)乙基]-1H-吡咯-3-甲酰胺;5'-O-乙?；?2'3'-O-異亞丙基腺苷 |
| CAS No.： | 356068-94-5 |
| 分子式： | C22H25FN4O2 |
| 分子量： | 396.46 |
| 純度： | 98% |
.png)
滬公網(wǎng)安備 31011502020044號(hào)
危險(xiǎn)化學(xué)品經(jīng)營許可證
水濤